TBT - Cardiovascular Disease
Update: 2024-07-19
Description
Welcome back Rounds Table Listeners!
In this throwback episode, Drs. Mike and John Fralick discuss the use of semaglutide in patients with obesity without diabetes and changes in renal function after starting dapagliflozin in patients with heart failure. Check it out below!
- Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial (0:00 – 09:40 ).
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (09:40 – 19:24 ).
And for the Good Stuff:
- How Ozempic and Weight Loss Drugs Are Reshaping Denmark’s Economy (19:24 – 19:58 ).
- How a Canadian scientist and a venomous lizard helped pave the way for Ozempic (19:58 – 23:36 ).
Questions? Comments? Feedback? We’d love to hear from you! @roundstable
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
